Pricing Log in Create free account

Verrica Pharmaceuticals Inc. (VRCA) vs XBiotech Inc. (XBIT)

Verrica Pharmaceuticals Inc. and XBiotech Inc. are both Biotechnology companies. Verrica Pharmaceuticals Inc. and XBiotech Inc. are of similar size ($65.9M and $64.9M). Verrica Pharmaceuticals Inc. grew revenue faster over the last twelve months: 106.2% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −102.8%) and the lower return on invested capital (−159.2% vs 0.00%). Across the 17 metrics below, XBiotech Inc. leads on 9 and Verrica Pharmaceuticals Inc. on 8.

Valuation

Metric VRCA XBIT Biotechnology median
P/E n/m n/m 8.50
P/S 2.49 16.12 9.71
P/B 17.51 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.74 0.64
EV/Sales 2.56 (8.64) 9.21
Earnings yield (47.18%) (69.81%) (33.15%)
Free cash flow yield (18.02%) (63.41%) (25.50%)

Profitability

Metric VRCA XBIT Biotechnology median
Gross margin 85.89% 0.00% 65.16%
Operating margin (93.59%) 0.00% 0.00%
Net margin (102.84%) 0.00% 0.00%
Free cash flow margin (44.02%) 0.00% 0.00%
Return on equity 473.29% (29.94%) (56.36%)
Return on assets (83.02%) (28.90%) (48.04%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric VRCA XBIT Biotechnology median
Revenue growth (TTM) 106.21% (78.20%) 6.02%
EPS growth (last fiscal year) 88.65% (18.25%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VRCA XBIT Biotechnology median
Debt to equity 0.18 0.00 0.00
Current ratio 1.45 33.15 4.72
Net debt to EBITDA 2.59 2.33 0.96

Dividend

Metric VRCA XBIT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric VRCA XBIT Biotechnology median
Market cap 64.93m 65.85m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack